临床儿科杂志 ›› 2021, Vol. 39 ›› Issue (10): 761-.doi: 10.3969/j.issn.1000-3606.2021.10.011

• 综合报道 • 上一篇    下一篇

婴幼儿肝血管瘤继发消耗性甲状腺功能减退症1例诊断及治疗

谢丽春 1, 游晶玉 1, 李国栋 2, 李长钢 1, 文飞球 1   

  1. 1 .深圳市儿童医院血液肿瘤科(广东深圳 518038);2 .深圳市坪山区妇幼保健院(广东深圳 518122)
  • 出版日期:2021-10-15 发布日期:2021-09-28
  • 通讯作者: 李长钢,文飞球 电子信箱:licg 6336 @sina.com,fwen 62 @ 126 .com

Diagnosis and treatment of consumptive hypothyroidism secondary to infantile hepatic hemangiomatosis: a case report

XIE Lichun1 , YOU Jingyu1 , Li Guodong2 , LI Changgang1 , WEN Feiqiu1   

  1. 1. Department of Hematology and Oncology, Shenzhen Children's Hospital, Shenzhen 518038 , Guangdong, China; 2 .Pingshan District Maternal and Child Health Hospital, Shenzhen 518122, Guangdong, China
  • Published:2021-10-15 Online:2021-09-28

摘要: 目的 探讨婴幼儿肝血管瘤的诊断及治疗。方法 回顾分析1例以反复贫血及先天性甲状腺功能减低症为 表现的肝脏多发灶性血管瘤婴儿的临床资料,并进行文献复习。结果 女性患儿生后2天诊断先天性甲状腺功能减低症, 口服左旋甲状腺素片,疗效欠佳。患儿2月龄时血红蛋白68 g/L,为正细胞正色素性贫血,网织红细胞计数升高,总胆红素、 游离胆红素、胆汁酸、甘氨胆酸及γ谷酰基转肽酶明显升高,促甲状腺素明显升高,游离T 3明显降低。肝脏超声示肝脏 实质内散在多个低回声团块,最大者位于肝右叶约8.9 cm×5.3 cm。腹部CT示肝脏体积明显增大,117 mm×145 mm× 90 mm,肝实质内见类圆形异常强化,呈多发性大小不等的囊性病变,周边可见稍高密度分隔影,胆囊分辨不清。诊断为 肝血管瘤,予加用普萘洛尔联合左旋甲状腺素片口服。治疗6个月后随访,腹部超声示肝脏血管瘤数量和大小都缩小一半, 肝酶及胆汁酸水平降至正常范围。逐渐减量左旋甲状腺素,甲状腺功能恢复正常,目前生长发育同正常同龄儿。结论 婴 儿肝脏血管瘤可导致严重并发症,及时诊断及治疗可明显改善预后。

关键词: 婴幼儿肝血管瘤; 消耗性甲状腺功能减退症; 早期诊断; 治疗

Abstract: Objective To investigate the diagnosis and treatment of infantile hepatic hemangioma (IHH). Methods The clinical data of an infant with hepatic multiple focal hemangioma presenting with recurrent anemia and congenital hypothyroidism was retrospectively analyzed and the related literatures were reviewed. Results Congenital hypothyroidism was diagnosed 2 days after birth in an infant baby girl, and oral levothyroxine treatment showed poor efficacy. At the age of 2 months, the hemoglobin was 68 g/L, and the reticulocyte count increased, and the blood routine examination suggested normal cellular anemia. Total bilirubin, unconjugated bilirubin, bile acid, glycholic acid and γ-glutamyl transpeptidase increased significantly, thyroid stimulating hormone increased significantly, and free T 3 decreased significantly. Ultrasonography showed that there were several hypoechoic masses scattered in the liver parenchyma, the largest one was located in the right lobe of liver with a size of about 8 . 9 cm×5 . 3 cm. Abdominal CT showed a significantly enlarged liver with a size of 117 mm×145 mm× 90 mm. In the liver parenchyma, there were abnormal enhancements of round shape, presenting multiple cystic lesions of varying sizes and slightly high-density septa surrounding the cystic lesions. The child was diagnosed with hepatic hemangioma and was given propranolol plus levothyroxine treatment. After 6 months of followup, abdominal ultrasonography showed that the number and size of hepatic hemangiomas had been reduced by half, and the levels of liver enzymes and bile acids had dropped to normal ranges. Therefore, the dosage of levothyroxine was gradually reduced, and the thyroid function of the child returned to normal. At present, the growth and development of the child are similar to those of normal age. Conclusions Infantile hepatic hemangioma can lead to serious complications, timely diagnosis and treatment can significantly improve the prognosis.

Key words: infantile hepatic hemangioma; consumptive hypothyroidism; early diagnosis; treatment